subject area of
- Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia Academic Article
- Lipogenesis inhibitors: therapeutic opportunities and challenges Academic Article
- Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis Academic Article
- Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders Academic Article